Skip to main content
Duk-Woo Park

Duk-Woo Park

Professor of Interventional Cardiology
Asan Medical Center, University of Ulsan College of Medicine
Dr. Duk-Woo Park was a Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine. Dr. Duk-Woo Park graduated from Kyoung-Hee Medical College and received medical degree from Kyoung-Hee Medical College and received M.S., Ph.D., degree from University of Ulsan College of Medicine. Dr. Duk-Woo Park subsequently did his Internal Medicine residency, Chief Residency, and Cardiology fellowship at the Asan Medical Center. Dr. Duk-Woo Park’s primary research interest has been in coronary revascularization treatments (PCI or CABG), PCI for left main disease, TAVR, antiplatelet therapies, biomarker, and stent studies. Dr. Duk-Woo Park has been the Investigator of many clinical trials conducted in the Asan Medical Center, Seoul, Korea. Dr. Duk-Woo Park was the first author on the primary results paper (REAL-LATE and ZEST-LATE trial) that was presented at ACC 2010 and published in the New England Journal of Medicine 2010 and the MAIN-COMPARE registry results paper that was presented at ACC 2008 and published in New England Journal of Medicine 2008. Dr. Duk-Woo Park has also authored or coauthored over 350 original, peerreviewed research articles. Especially, Dr. Duk-Woo Park has major contributions as the principal (first or corresponding) authors in top medical journals (2 NEJM, 1 JAMA, 25 JACC, 5 Circulation, 2 EHJ) within last 20 years. By the remarkable academic achievements, Dr. DukWoo Park was awarded with Douglas P. Zipes Distinguished Young Scientist Award at the 2012 ACC (American College of Cardiology), Chicago, IL, United States. Dr. Duk-Woo Park has now a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major clinical trials or registries studies (drugs, stents, revascularization strategy), biomarkers, and medical statistics. Dr. Duk-Woo Park is now a Deputy Editor in JACC Asia.